Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Pharmacist's call after discharge slash readmissions?

NCT ID NCT04071951

Disease control Sponsor: Cedars-Sinai Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether having a pharmacist review medications and counsel patients before and after hospital discharge can reduce return trips to the hospital or ER within 30 days. Over 6,400 older adults (55+) taking many medications or high-risk drugs are taking part. The pharmacist helps with medication lists, adherence, and simplifying complex drug regimens.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pharmacist-led medication management and counseling
What this could lead to
If it works, this could reduce hospital readmissions and emergency visits for older adults taking many medications.
What could go wrong
This is a behavioral intervention, not a drug, so results may vary by hospital and patient adherence. The study is pragmatic, meaning real-world factors could dilute the effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

6,478 people

The number who actually took part.

Started

Dec 2019

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Admitted to a medical ward, AND * \> 55 years AND * ≥ 10 prescription medications at admission OR • ≥ 3 high-risk medications (anticoagulants, antiplatelets, insulin, oral hypoglycemics) at admission Exclusion Criteria: * Expected discharge to another state, acute care facility, psychiatric facility, or locked facility (including locked skilled nursing facility, jail, or prison) OR * Expected AMA or left hospital against medical advice (AMA) OR * Homeless OR * On hospice OR * Already enrolled into study within the past year OR * Patients admitted by admitting or attending Primary Medical Doctors who have a specialty that is not Internal Medicine or Family Medicine OR * Expected to receive pharmacist-led peri- and post-discharge medication management regardless of the trial OR * Expected post-discharge setting not conducive to the studied medication management intervention (e.g. SNF, rehabilitation facility) OR * Patients admitted with a suspected or confirmed diagnosis of COVID-19.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nonadherence, patient are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Patient Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Nonadherence, patient Polypharmacy Readmission

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

  • Cedars-Sinai Medical Center

    Los Angeles, California, 90048, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.